Skip to main content

Accelerate discovery and clinical translation

We have a responsibility to conduct high impact research that ultimately makes a difference in people’s lives. We need to increase the depth, breadth and quality of our research. This will attract more talent and research funding and help us move faster in reaching our ultimate goal, which is preventing disease, alleviating suffering and saving lives.

yellow circle with outline of microscope, beaker and books

Goals

  • Increase the impact of scientific discovery and clinical translation.
  • Increase NIH funding to be in the top 10 public medical schools by 2030.
  • Diversify sources of research funding, including increasing focus on industry partnerships. 
  • Increase the number of patients enrolled in clinical trials to ensure clinical research adequately reflects the people of Indiana.
  • Increase the national recognition of our faculty and staff.

Objectives

  • Build interdisciplinary team-based programs in areas where IU School of Medicine can be a national leader (within institutes and in other priority areas).
  • Balance recruitments to support bench to bedside programs.
  • Recruit more researchers in population health, community health and health care access.
  • Address basic science and clinical research infrastructure needs, particularly in areas of critical staffing shortages.
  • Enhance support for developing programmatic funding proposals.
  • Increase the number of MD/PhD students and create programs to better support physician-scientist career development.
  • Formalize mentoring program for midcareer faculty.

Metrics

 

Raise total research funding to $600 million by 2030.

The school was awarded $548 million in research funding in 2025.

The total dollar amount of research awards received per calendar year. Multi-year awards are prorated over duration of the project.

Data displayed is for the 2025 calendar year.

Updated June 29, 2026

 

 

Increase NIH research funding to $378 million by 2030.

The school was awarded $233 million in research funding from the NIH in 2025.

The total dollar amount of National Institute of Health awards received per calendar year. Multi-year awards are prorated over duration of the project.

Data displayed is for the 2025 calendar year.

Updated June 29, 2026

 

 

Advance the school's Blue Ridge ranking for public medical schools to top 10.

IU School of Medicine was ranked 15th in the Blue Ridge rankings for public medical schools in 2025.

 

IU School of Medicine's ranking among public medical schools on the annual report from Blue Ridge Institute for Medical Research.

Data displayed is for the 2025 federal fiscal year.

Updated June 29, 2026

Share your feedback

We encourage bidirectional communication with our faculty, staff, learners, alumni and broader community. Please share your ideas on how to make the School of Medicine and our work better.

Recent Stories

A young man sits at an electronic keyboard. The side of his head has bald patches in his dark hair.

Clinical trial helps IU student regrow hair using first-of-its-kind drug for autoimmune alopecia

As a participant in a clinical trial for alopecia areata at the IU School of Medicine, Elijah Crysell experienced significant new hair growth on the drug Rezpeg.

November 18, 2026

two researchers in white coats work near a hood in a laboratory

IU researchers team up to create multicellular human models to study genetic and environmental factors in ALS and Parkinson’s disease

IU School of Medicine experts in neurodegeneration, stem cell biology and data science are collaborating to build human stem-cell based models focused on better understanding Parkinson’s disease and ALS.

November 17, 2026

Headshot of Agnes Zybura Wardrop on black background. She is light skinned with long, dark hair and is wearing glasses.

IU-trained neuroscientist helps fuel drug development at Indiana biotech startup

IU School of Medicine’s PhD programs serve as a workforce pipeline for Indiana biotech companies. Agnes Wardrop graduated with a PhD in medical neuroscience in 2021 and now works for Syndeio Biosciences, an IU-connected startup.

October 20, 2026